Servier
Founded by : Jacques Servier, 1 January 1954
About the Company
Founded with a focus on healthcare, Servier is a global organization overseen by a Foundation with a mission to create a positive social impact for patients and the environment. Their unique governance model allows them to fulfill their purpose with a long-term outlook: advancing medical treatments to meet patient needs. The Group's 21,900 employees are dedicated to this shared mission, which inspires them every day.
As a leader in cardiology, Servier aims to become a key player in oncology by targeting challenging cancers. Over 70% of their research and development budget is dedicated to developing innovative therapies in this field. Additionally, Servier sees neuroscience and immuno-inflammatory diseases as future growth areas. They focus on a select number of diseases where precise patient profiling enables tailored treatment through precision medicine.
To ensure access to quality healthcare at affordable prices, Servier offers a range of high-quality generic drugs covering a wide range of conditions. They rely on strong brand presence in France, Eastern Europe, Brazil, and Nigeria. Throughout their work, Servier prioritizes the patient's perspective at every stage of a medicine's life cycle.
Headquartered in France, Servier operates in over 150 countries and achieved revenue of €4.3 billion in 2023.
If you need to report a suspected adverse event related to a Servier drug, please visit servier.com.
Industry Type
- Sector: Health Care
- Industry group: Pharmaceuticals, Biotechnology & Life Sciences
- Industry: Pharmaceuticals
- Sub-Industry: Pharmaceuticals
Company Address
Source : Google maps